Prime Medicine operates as a biotechnology company that delivers the promise of gene editing using Prime Editing.
Details
Industries BiotechnologyGeneticsLife ScienceMedicalHeadquarters Regions Greater Boston Area, East Coast, New England Founded Date 2019 Founders Andrew Anzalone, David R. Liu Operating Status Active Last Funding Type Undisclosed Legal Name Prime Medicine, Inc. Hub Tags Exited Unicorn
Stock Symbol NASDAQ:PRME Company Type For Profit
Contact Email info@primemedicine.com
Prime Medicine is a biotechnology company founded to deliver on the promise of Prime Editing, a versatile gene editing technology that can truly "search and replace" to restore normal genetic function and address the fundamental causes of disease.
Products and Services
Product Name | Product Description |
---|---|